Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DHX9 is a member of the DExH/D box family of RNA helicases. It is an NTP-dependent helicase with the ability to unwind both DNA and RNA duplexes as well as more complex nucleic acid structures. It plays central roles in multiple aspects of nucleic acid metabolism including RNA metabolism, DNA metabolism, transcriptional regulation, genome integrity, and innate immunity. High levels or dysregulation of DHX9 are associated with poor prognosis in several cancers, making it a promising target for oncology research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEAH-box helicase 9 (DHX9).